Boston Scientific Profit Margin

Boston Scientific (BSX-PA) currently reports a profit margin of 17.47% as of June 2026. That compares with 13.54% in the prior-year period — up 28.9% year over year. That is above the Healthcare sector average of 13.39%. Use the charts on this page to explore Boston Scientific's profit margin history and peer comparisons.

Boston Scientific's profit margin increased from 13.54% to 17.47% — a 28.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Boston Scientific's profit margin of 17.47% is higher than the Healthcare sector average of 13.39%. That is roughly 30.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Boston Scientific's current 17.47% should be judged against Healthcare norms (sector average: 13.39%) and against BSX-PA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 17.47%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.39%. From there, open related valuation or income-statement pages for Boston Scientific, and consider following BSX-PA for alerts when major investors trade the stock.